News

DSM acquires BioCare Copenhagen

30 Dec 2017

DSM has acquired BioCare Copenhagen. With the acquisition, DSM expands its offering in gut health ingredients with probiotics, which it believes is an attractive market segment.

DSM has acquired BioCare Copenhagen. With the acquisition, DSM expands its offering in gut health ingredients with probiotics, which it believes is an attractive market segment in nutritional ingredients, growing an estimated 7% per year.

BioCare Copenhagen is a privately-held company founded in 2012, focused on probiotics and specialized in microbial actives with proven health benefits, targeting gastrointestinal disorders, metabolic disorders, infections, and immunity. The company offers white label probiotic supplements and complete product concepts. BioCare Copenhagen has multi-market distribution agreements with a number of dietary supplements and pharmaceutical companies and has launched products in over 40 countries worldwide.

DSM says it already has a strong position in gut health solutions with its Culturelle product range as well as with its ingredient brands Oatwell and Tolerase. The company said it sees further growth potential in gut health ingredients beyond the established indications for digestive health and immune health. Fields increasingly recognised as being impacted by the gut microbiome include the gut-brain axis, metabolic health and heart health. DSM’s ambition in addressing the gut microbiome and its portfolio of nutritional ingredients are said to be very synergistic with BioCare Copenhagen’s approach and products, and the combination is well-catered to address the existing and emerging gut health areas.